Announcements Trials

Browse Landscape

Phase

Phase 3 3 Phase NA 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 2 Breast Neoplasms 2 Sarcoma, Ewing 1 NSCLC 1 Lymphoma, T-Cell, Peripheral 1 HER2 Positive Breast Cancer 1 Carcinoma, Non-Small-Cell Lung 1 Carcinogenesis 1

Interventions

sugemalimab 1 spartalizumab 1 Vinorelbine 1 Radiotherapy 1 Pemetrexed 1 Paclitaxel 1 Liquid Biopsy 1 Gemcitabine 1 Gefitinib 1 Erlotinib Hydrochloride 1 Drug Therapy 1 Docetaxel 1 Cryotherapy 1 Anterior Temporal Lobectomy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × NSCLC × Vinorelbine × Clear all

NCT06576635 2026-01-20

LUNG-05

University of Illinois at Chicago

Phase NA Recruiting

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡